GLP-1s approved for diabetes include Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), and Victoza (liraglutide)
doi: 10.1016/j.bbrc.2019.01.103 49 BomfimTRForny-GermanoLSathlerLBBrito-MoreiraJHouzelJCDeckerHet al
[1] [2] The half-life of a medicationthe time required for the body to eliminate half of the drug's concentrationis the primary determinant of how long a GLP-1 receptor agonist remains in your system
We went through these issues with thyroid cancer, pancreatitis, pancreas cancer
[END CALLOUT BOX] GLP2 Research Applications & Key Findings Type 2 Diabetes Management SURPASS Clinical Trial Program The SURPASS phase 3 clinical program enrolled over 6,000 participants across five global registration trials, evaluating GLP2 across the type 2 diabetes treatment continuum
Tirzepatide is unique as a dual GIP and GLP-1 receptor agonist